Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Kasturba Medical College, Manipal
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Gastric Signet Ring Cell Carcinoma and receiving standard therapy at the therapy. Patients who underwent surgery for Gastric Signet Ring Cell Carcinoma from 2019 to the present.
Exclusion criteria
Exclusion criteria: Patients diagnosed with Stage 4 Gastric Signet Ring Cell Carcinoma. Patients are not fit for Surgery or Chemotherapy. Patients receiving Neoadjuvant Therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcomes of this study include a better understanding of why signet ring cell carcinoma is so aggressive, as well as the identification of key genes and pathways involved in tumor growth and drug resistance. The research aims to discover potential new targets for more effective and personalized treatments. By testing various drugs on these cancer cells in the lab, the study will provide insights into which therapies are most promising. Ultimately, these findings are expected to lead to improved treatment strategies and better outcomes for patients with this challenging type of cancer.Timepoint: Three years | — |
Secondary
| Measure | Time frame |
|---|---|
| Discovery of new biomarkers, such as specific proteins or genetic markers, that aid in early diagnosis or monitoring the effectiveness of treatments. The research might also provide a clearer understanding of why some patients develop resistance to chemotherapy over time, allowing for better management of treatment plans.Timepoint: Three years | — |
Countries
India
Contacts
Public ContactDr Naveena Kumar A N
Manipal Academy of Higher Education
Outcome results
None listed